Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roof at our 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series, hosted on October 3-5, 2023.
Cancer Research & Immuno-Oncology Week 2023 will offer a 3-day content-rich program providing invited lectures, thought-provoking discussions and posters to explore global developments and advancements in the prevention, diagnosis, and treatment of different cancer types. Each year, we see progress in immunotherapy and treatments in targeted and personalized therapeutics and drug development, and a decrease in mortality rates due to a strong focus on learning more about the origination of the disease.
Recent breakthroughs in immuno-oncology research translate into a paradigm shift to attacking cancer, and the benefits of immuno-oncology have resulted in long-lasting tumor regression where surgery, radiotherapy, chemotherapy, and targeted therapy proved less effective. As immuno-oncology is considered by some to be one of the most promising areas of research in the world of anti-cancer therapeutics, you'll also learn from experts how immunotherapies can work alone, together, or in a combination with other treatments to fight cancer.
The topics and tracks for this year's event include:
Day 1- Cancer Research:
Novel Targeted Therapies in Cancer:
Day 2- Immuno-Oncology:
Cell Therapy:
Day 3- Cancer Research Networks, Epidemiology, and Patient Advocacy:
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2023 Cancer Research and Oncology Virtual Event. Submission is free. Submit your abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global cancer research and immuno-oncology community with a high degree of interaction through live-streaming video and chat sessions.
Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 35 credits.
Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.
Connect with us!
When you attend the event remember to use the hashtag #LRcancer to follow the conversation and connect with other members of the global Cancer & Oncology Research community! Follow @Cancer_LR on Twitter and @CancerResearchandOncology.LR on Facebook to connect with our specialist Cancer & Oncology writers and stay up to date with the latest news in Cancer & Oncology Research.
Now, you can also join our Cancer Research & Oncology networking group on LinkedIn!
Assistant Professor, Department of Leukemia, Department of Genomic Medicine, UT MD Anderson Cancer Center
Associate Professor, Biomedical Informatics, Mayo Clinic College of Medicine
Manager, Cell Imaging Applications at Sartorius
Segment Marketing Manager, GenScript
Technical Account Manager, Sino Biological
Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP) Program Director, Harvard Molecular Genetic Pathology Fellowship Chair, Training & Education Committee, Association for Molecular Pathology Assistant Professor, Harvard Medical School, Boston Children's Hospital
Chief Science Officer, U.S. Urology Partners, Clinical Assistant Professor, Department of Urology, Vanderbilt School of Medicine
VP of Sales, Alamar Biosciences
Senior Segment Marketing Manager- Antibody Drug Discovery, GenScript USA Inc.
Deputy Associate Director of Diversity, Equity, Inclusion, and Access (DEIA), The University of Colorado Cancer Center, Associate Professor of Immunology & Microbiology,
The Margaret Turley Grohne Chair in Translational Cancer Research
Director Scientific & Technical Affairs, Thermo Fisher Scientific
Director of Radiation Oncology, Associated Medical Professionals of New York (AMP)
Senior Product Manager, Thermo Fisher Scientific
Assistant Professor, Department of Industrial and Physical Pharmacy, Purdue University
Key Account Manager - Lab Digitalization Specialist, eLabNext
Medical Director, AdventHealth Global Robotics Institute, Medical Director, AdventHealth Cancer Institute Urologic Oncology Program, Professor of Urology, University of Central Florida
Senior Segment Marketing Manager, Cell Therapy, GenScript USA Inc.
Principal Investigator, Ben Towne Center for Childhood Cancer Research, SCRI, Assistant Professor, Department of Pediatrics, UW School of Medicine, Affiliate Faculty, Human Biology Division, Fred Hutchinson Cancer Center
Head of Product Development and Manufacturing, GenScript Innovation Center
Professor of Computational Biology and Bioinformatics, Chair of the Department of Biostatistics, Harvard University, Dana-Farber Cancer Institute
Founder, Chief Executive Officer, Chief Medical Officer, and Board of Trustees Chair, Nonagen Bioscience
PGY-3, Department of Pathology, Stanford Health Care
Secretary General, Endourological Society, Pete and Carolyn Newsome Professor of Urologic Oncology, Chair, Department of Urology, University of Florida College of Medicine
Senior Scientist, CloudLIMS
Associate Consultant, Department of Quantitative Health Sciences, Assistant Professor of Biomedical Informatics, Mayo Clinic College of Medicine and Science
Staff Scientist, Fred Hutchinson Cancer Center
OriGene Technologies was founded as a research tool company focused on the creation of the large commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based ...
See moreThe Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and ...
See moreAtlas Antibodies is a Swedish biotechnology company driving leading research worldwide through providing affinity-purified monoclonal and polyclonal antibodies, and control antigens. Our product portfolio extensively covers human proteins in cells, tissues, and organs. With our ...
See moreDIMA Biotechnology Ltd. is a top biotech company specializing in preclinical research and development solutions for the Biopharma industry. We offer a wide range of pre-designed and validated antibody molecules for early-stage drug development, perfectly tailored to the research ...
See moreAbsolute Biotech specializes in antibody reagents, kits and services, adding value to existing antibodies through annotation, validation, sequencing, engineering and recombinant manufacturing. Our company unites multiple antibody-centric brands to offer customers worldwide the ...
See moreThermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving ...
See moreAt Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic ...
See moreSino Biological, Inc. is a global leader in manufacturing affordable, high-quality reagents, including recombinant proteins, antibodies and cDNA clones-all in-house. We provide a one-stop shop for researchers and pharmaceutical companies around the world, helping our customers ...
See moreFor 60 years The Baker Company has been at the forefront of engineering, testing and production of reliable laboratory contamination control equipment. Recognized as the industry pioneer, The Baker Company maintains an unparalleled passion for helping our customers advance ...
See moreDigital lab solutions for any laboratory need. Improve the quality of your life science research, optimize your workflow and increase productivity with eLabNext lab management software.
We are creating the most sensitive proteomics platform that can profile thousands of proteins simultaneously from as little as one microliter of plasma. Our fully automated, high throughput platform will unmask new biomarkers for early detection and prevention of common diseases ...
See moreThe speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Dr. David M. Albala graduated with a geology degree from Lafayette College in Easton, Pennsylvania. He completed his medical school training at Michigan State University and went on to complete his surgical residency at the Dartmouth-Hitchcock Medical Center. Following this, Dr ...
See moreDr. Yan Asmann is an Associate Professor of Biomedical Informatics at Mayo College of Medicine. Her research focuses on developing analytical algorithms and frameworks for multi-omics data mining, modeling, and integration. Dr. Asmann has applied these methods to study complex ...
See moreTullia C. Bruno, PhD, is an Assistant Professor in the Department of Immunology at the University of Pittsburgh and a faculty member in the Tumor Microenvironment Center and the Cancer Immunology and Immunotherapy Program at the UPMC Hillman Cancer Center. She obtained her Ph.D ...
See moreKeith L. Knutson, Ph.D., is a consultant in the Department of Immunology, Mayo Clinic in Florida, where he also serves as director of the Discovery and Translation Lab's Cancer Research Program. Dr. Knutson joined the staff of Mayo Clinic in 2005 and holds the academic rank of ...
See moreJonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...
See moreDr. Shannon Oda earned a Ph.D. in Immunology from the University of Colorado Anschutz Medical Campus and completed her postdoctoral training with Dr. Philip Greenberg at the Fred Hutchinson Cancer Research Center. She has received several awards, including the Evergreen Fund ...
See moreJohn Quackenbush is Professor of Computational Biology and Bioinformatics and Chair of the Department of Biostatistics at the Harvard TH Chan School of Public Health and Professor at the Dana-Farber Cancer Institute. John's PhD was in Theoretical Physics but a fellowship to work ...
See moreMontserrat Valdes is a highly skilled chemical engineer with a diverse background in research and industry. She holds a Master of Science degree in Chemical Engineering from the University of Saskatchewan and an Analytical Chemistry Diploma from the National Autonomous University ...
See more